Related Experiment Video
Updated: Feb 17, 2026

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
Published on: April 18, 2025
LDB2 inhibits proliferation and migration in liver cancer cells by abrogating HEY1 expression
Hongyang Yu1, Ruichun Jia2, Ling Zhao3
1Department of Radiation Oncology, The Second Affiliated Hospital, Harbin Medical University, Harbin 150086, China.
Abstract:
Hepatocellular carcinoma (HCC) was one of the most common cancers around the world, has very low 5-year survival rate. However, the mechanism of HCC occurrence and development is largely unknown. LDB2 belongs to the LIM-domain binding family and functions as an adaptor for transcriptional regulation. Here we found that LDB2 is downregulated in HCC samples. LDB2 has the ability to inhibit proliferation and migration of hepatocarcinoma cells. We found that the proliferation and migration abilities in HCC sample cells were impaired after LDB2 overexpression and vice versa. In mechanism, we found that LDB2 can recruit BRD7 to HEY1 promoter and then block its expression. HEY1 whose expression is upregulated in HCC acts as an oncogene. In brief, our research reveals a new regulatory mechanism for hepatocarcinoma cell proliferation and migration.
Insights
Liver cancer progression, hepatocellular carcinoma (HCC), is linked to reduced LDB2 levels. Restoring LDB2 inhibits cancer cell growth and migration by regulating HEY1 expression.
Area of Science:
- Oncology
- Molecular Biology
- Gene Regulation
Background:
- Hepatocellular carcinoma (HCC) is a prevalent cancer with poor survival rates.
- The molecular mechanisms driving HCC development remain largely unclear.
- LIM-domain binding protein 2 (LDB2) is involved in transcriptional regulation.
Purpose of the Study:
- To investigate the role of LDB2 in hepatocellular carcinoma.
- To elucidate the mechanism by which LDB2 affects HCC cell proliferation and migration.
Main Methods:
- Analysis of LDB2 expression in HCC patient samples.
- Overexpression and knockdown experiments to assess LDB2 function in HCC cells.
- Investigation of LDB2's interaction with BRD7 and HEY1 promoter.
Main Results:
- LDB2 expression is significantly downregulated in HCC tissues.
- LDB2 overexpression suppresses HCC cell proliferation and migration.
- LDB2 recruits BRD7 to the HEY1 promoter, inhibiting HEY1 expression.
- HEY1 is upregulated in HCC and functions as an oncogene.
Conclusions:
- LDB2 acts as a tumor suppressor in HCC by inhibiting proliferation and migration.
- The LDB2-BRD7-HEY1 pathway represents a novel regulatory mechanism in HCC.
- Targeting this pathway may offer therapeutic strategies for HCC.
Related Concept Videos
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Inhibition of Cdk Activity
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

